1 Center for Integrative Brain Research Seattle Children's Research Institute Seattle WA.
2 Division of Cardiology Department of Medicine University of Washington Seattle WA.
J Am Heart Assoc. 2019 Jun 4;8(11):e011260. doi: 10.1161/JAHA.118.011260.
Background Protein posttranslational modifications by O-linked β-N-acetylglucosamine (O-GlcNAc) increase with cardiac hypertrophy, yet the functional effects of these changes are incompletely understood. In other organs, O-GlcNAc promotes adaptation to acute physiological stressors; however, prolonged O-GlcNAc elevations are believed to be detrimental. We hypothesize that early O-GlcNAcylation improves cardiac function during initial response to pressure overload hypertrophy, but that sustained elevations during established pathological hypertrophy negatively impact cardiac function by adversely affecting calcium handling proteins. Methods and Results Transverse aortic constriction or sham surgeries were performed on littermate controls or cardiac-specific, inducible O-GlcNAc transferase knockout (OGTKO) mice to reduce O-GlcNAc levels. O-GlcNAc transferase deficiency was induced at different times. To evaluate the initial response to pressure overload, OGTKO was completed preoperatively and mice were followed for 2 weeks post-surgery. To assess prolonged O-GlcNAcylation during established hypertrophy, OGTKO was performed starting 18 days after surgery and mice were followed until 6 weeks post-surgery. In both groups, OGTKO with transverse aortic constriction caused significant left ventricular dysfunction. OGTKO did not affect levels of the calcium handling protein SERCA2a. OGTKO reduced phosphorylation of phospholamban and cardiac troponin I, which would negatively impact cardiac function. O-GlcNAcylation of protein kinase A catalytic subunit, a kinase for phospholamban, decreased with OGTKO. Conclusions O-GlcNAcylation promotes compensated cardiac function in both early and established pathological hypertrophy. We identified a novel O-GlcNAcylation of protein kinase A catalytic subunit, which may regulate calcium handling and cardiac function.
背景 蛋白的 O-连接 β-N-乙酰氨基葡萄糖(O-GlcNAc)的翻译后修饰随着心脏肥大而增加,但这些变化的功能影响尚不完全清楚。在其他器官中,O-GlcNAc 促进对急性生理应激的适应;然而,持续升高的 O-GlcNAc 被认为是有害的。我们假设,在对压力超负荷肥大的初始反应中,早期 O-GlcNAc 化可改善心脏功能,但在已建立的病理性肥大期间持续升高会通过不利地影响钙处理蛋白而对心脏功能产生负面影响。
方法和结果 在同窝对照或心脏特异性、诱导型 O-GlcNAc 转移酶敲除(OGTKO)小鼠中进行横主动脉缩窄或假手术,以降低 O-GlcNAc 水平。在不同时间诱导 O-GlcNAc 转移酶缺乏。为了评估对压力超负荷的初始反应,在术前完成 OGTKO,并且在手术后 2 周内对小鼠进行随访。为了评估在已建立的肥大期间持续的 O-GlcNAc 化,在手术后 18 天开始进行 OGTKO,并在 6 周后对小鼠进行随访。在这两组中,横主动脉缩窄的 OGTKO 导致左心室功能显著受损。OGTKO 不影响钙处理蛋白 SERCA2a 的水平。OGTKO 降低了磷蛋白和心肌肌钙蛋白 I 的磷酸化,这会对心脏功能产生负面影响。蛋白激酶 A 催化亚基的 O-GlcNAc 化,即磷蛋白的一种激酶,随着 OGTKO 而减少。
结论 O-GlcNAc 化在早期和已建立的病理性肥大中均促进代偿性心脏功能。我们鉴定了一种新的蛋白激酶 A 催化亚基的 O-GlcNAc 化,其可能调节钙处理和心脏功能。